Cartilage, recognized as one of the most resilient tissues in the human body, often faces irreversible damage. When it deteriorates, it can lead to osteoarthritis, a painful condition that restricts movement and may necessitate joint replacement surgeries for millions.
In a groundbreaking study featured in Science, researchers have revealed a novel technique to stimulate the regrowth of healthy cartilage in aging and injured mice. This innovative approach involves inhibiting a specific enzyme associated with aging. Remarkably, this method also exhibited early signs of cartilage regeneration in human samples obtained from knee replacement procedures.
This research indicates that the loss of cartilage, previously deemed unmanageable, could potentially be addressed at its root cause.
The Enzyme Linked to Aging
As individuals age, the protective cartilage surrounding bones tends to thin out. Unlike other tissues, cartilage lacks a natural renewal mechanism.
The study identifies an enzyme known as 15-PGDH as a key factor in this decline. The enzyme's levels increase with age across various tissues, earning it the moniker "gerozyme."
When comparing knee cartilage from younger and older mice, researchers observed that 15-PGDH levels surged nearly twofold with age. Additionally, these levels rose following joint injuries, similar to those that can lead to osteoarthritis in humans.
This observation piqued the researchers' interest, as 15-PGDH is known to degrade molecules essential for tissue repair. Previous studies indicated that blocking this enzyme enabled aging mice to rebuild muscle and enhance strength, leading the team to explore whether cartilage might respond similarly.
To investigate, the team administered a small-molecule drug that inhibits 15-PGDH to older mice. Some received systemic treatment, while others received direct injections into the knee. In both scenarios, the cartilage, which had previously appeared thin and damaged, showed significant thickening across the joint surface.
Further analysis confirmed that the newly formed tissue was hyaline cartilage, the healthy type typically found in functional joints, rather than the stiffer fibrocartilage that often arises from unsuccessful repair attempts.
"The extent of cartilage regeneration in aged mice was astonishing," stated Nidhi Bhutani, an orthopedic scientist and lead author of the study. "The results were remarkable."
Reprogramming Rather Than Replacing
The treatment not only facilitated recovery after joint injuries but also reduced the likelihood of developing osteoarthritis in mice with knee damage akin to torn ACLs. Those treated with enzyme-blocking injections showed improved mobility and reduced discomfort compared to untreated counterparts.
What surprised researchers most was the mechanism of recovery. For years, the scientific community has sought stem cells capable of repairing damaged cartilage, yet these elusive cells were not required in this case.
Rebuilding Cartilage
Instead of relying on stem cells, the research team examined the existing cartilage cells. By employing a technique to monitor gene activity in individual cells, they discovered that aging and injury prompted many cartilage cells to enter a detrimental state, producing 15-PGDH and other molecules that degrade cartilage. Concurrently, cells that typically support healthy cartilage became less abundant.
Inhibiting 15-PGDH reversed this trend, leading to a decrease in breakdown-related cells and an increase in those responsible for maintaining and constructing smooth, healthy cartilage.
"This represents a novel approach to adult tissue regeneration, holding significant clinical promise for treating age-related or injury-induced arthritis," remarked Helen Blau, a stem cell biologist and senior author of the study. "Our focus was on stem cells, but they were clearly not necessary. This is incredibly exciting."
The findings suggest that cartilage retains its ability to repair itself well into adulthood, although this capacity appears to be diminished with age, rather than permanently lost.
Initial Signs in Human Tissue
To determine if human cartilage could respond similarly, researchers examined tissue removed during knee replacements. After treating osteoarthritis samples with the 15-PGDH inhibitor for a week, they observed decreased enzyme levels and early signs of cartilage regeneration.
"The mechanism is quite remarkable and has significantly shifted our understanding of tissue regeneration," Bhutani noted. "A substantial pool of existing cartilage cells appears to be altering their gene expression patterns."
This research aligns with a broader initiative to develop treatments that address osteoarthritis directly, rather than merely alleviating symptoms. With around one in five adults in the United States affected by this condition, which incurs substantial healthcare costs, this enzyme-blocking strategy seeks to tackle the underlying causes of degeneration.
While an oral version of the 15-PGDH inhibitor is already in early clinical trials for muscle weakness related to aging, further research is necessary to evaluate its efficacy in joint diseases. Despite the challenges, this study refutes the long-held belief that adult cartilage is beyond repair, suggesting instead that aging joints may simply be operating in a less optimal state.
